Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Multicentre Cluster Randomised Stepped Wedge Trial of Opioid Sparing Analgesia in Emergency General Surgery.

Created on 18 Aug 2026

Authors

Chao Ren, Shicao Li, Tian Zhang, Jing Ding

Published in

ANZ journal of surgery. Aug 17, 2026. Epub Aug 17, 2026.

Abstract

Emergency general surgery (EGS) is associated with high postoperative pain burden and historically relies on opioid-centric analgesia, which can delay recovery and increase opioid-related adverse events and longer-term exposure. Evidence for scalable, system-level opioid-sparing pathways in pragmatic emergency surgical settings remains limited, particularly in Asian tertiary health systems.
We conducted a pragmatic, multicentre and cluster-randomised stepped-wedge trial in 12 Chinese tertiary hospitals comparing usual care with a structured multimodal opioid-sparing perioperative analgesia pathway. The primary outcome was cumulative 48-h postoperative opioid consumption (oral morphine milligram equivalents, MME). Secondary outcomes assessed pain, recovery, safety and post-discharge opioid exposure. Mixed-effects models accounted for clustering and period effects.
Of 3646 enrolled patients, primary outcome data were available for 3561 (97.7%). Mean 48-h opioid consumption decreased from 64.2 to 46.1 MME, with an adjusted reduction of -18.1 MME (95% CI = -21.4 to -14.7; p < 0.001) and a ratio of means of 0.76 (95% CI = 0.72-0.80; p < 0.001). High opioid exposure (> 100 MME) declined (17.2% vs. 9.9%; OR = 0.52), while opioid-free status at 48 h increased (8.0% vs. 17.7%; OR = 2.47) (both p < 0.001). Pain burden, recovery metrics, opioid-related adverse events and persistent opioid use at 30 days all favoured the intervention.
A structured opioid-sparing pathway reduced early postoperative opioid exposure and improved recovery and safety outcomes in EGS, supporting wider implementation of multimodal opioid stewardship.

PMID:
42608324
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement